Related references
Note: Only part of the references are listed.Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation
Delai Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
Rosemary L. Kanasty et al.
MOLECULAR THERAPY (2012)
Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
Warefta Hasan et al.
NANO LETTERS (2012)
Self-assembled RNA interference microsponges for efficient siRNA delivery
Jong Bum Lee et al.
NATURE MATERIALS (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Cationic Lipid-Coated Gold Nanoparticles as Efficient and Non-Cytotoxic Intracellular siRNA Delivery Vehicles
Won Ho Kong et al.
PHARMACEUTICAL RESEARCH (2012)
Current progress of siRNA/shRNA therapeutics in clinical trials
John C. Burnett et al.
BIOTECHNOLOGY JOURNAL (2011)
Synergistic Silencing: Combinations of Lipid-like Materials for Efficacious siRNA Delivery
Kathryn A. Whitehead et al.
MOLECULAR THERAPY (2011)
Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner et al.
NATURE BIOTECHNOLOGY (2011)
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
Daniel J. Siegwart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Five Years of siRNA Delivery: Spotlight on Gold Nanoparticles
Abigail K. R. Lytton-Jean et al.
SMALL (2011)
Combinatorial Approach to Determine Functional Group Effects on Lipidoid-Mediated siRNA Delivery
Kerry P. Mahon et al.
BIOCONJUGATE CHEMISTRY (2010)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Biocompatibility and drug delivery systems
Daniel S. Kohane et al.
CHEMICAL SCIENCE (2010)
Gene Regulation with Polyvalent siRNA-Nanoparticle Conjugates
David A. Giljohann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver
Akin Akinc et al.
MOLECULAR THERAPY (2009)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
David B. Rozema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
A. Santel et al.
GENE THERAPY (2006)
PAMAM dendrimers for efficient siRNA delivery and potent gene silencing
Jiehua Zhou et al.
CHEMICAL COMMUNICATIONS (2006)
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
F Takeshita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Kanamycin A-derived cationic lipids as vectors for gene transfection
M Sainlos et al.
CHEMBIOCHEM (2005)
2-deoxystreptamine: Central scaffold of aminoglycoside antibiotics
GF Busscher et al.
CHEMICAL REVIEWS (2005)
siRNAs: Applications in functional genomics and potential as therapeutics
Y Dorsett et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Unlocking the potential of the human genome with RNA interference
GJ Hannon et al.
NATURE (2004)
Enhancement of the growth of human endothelial cells by surface roughness at nanometer scale
TW Chung et al.
BIOMATERIALS (2003)
Aminoglycoside (neomycin) preference is for A-form nucleic acids, not just RNA: Results from a competition dialysis study
DP Arya et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Targeting RNA: new opportunities to address drugless targets
GJR Zaman et al.
DRUG DISCOVERY TODAY (2003)
Aminoglycoside-derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo
P Belmont et al.
JOURNAL OF GENE MEDICINE (2002)
Determination of minimum inhibitory concentrations
JM Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Neomycin-acridine conjugate: A potent inhibitor of Rev-RRE binding
SR Kirk et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
PD Zamore et al.
CELL (2000)